ISRCTN98741793已完成3 期
A phase III trial comparing a cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP) regimen to a mitoxantrone, cyclophosphamide, etoposide, bleomycin, vincristine and prednisolone (PMItCEBO) regimen with or without granulocyte colony-stimulating factor (G-CSF) in patients aged sixty years plus with non-hodgkin's lymphoma
ymphoma Research Trust (UK)0 个研究点目标入组 880 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 880
研究概览
简要总结
2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19450285
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged at least 60 years
- •2. Newly presenting aggressive non-Hodgkin's lymphoma
- •3. Bulky stage IA and stages IB - IV
- •4. Patients must be free from any other irreversible medical condition that would drastically limit their life span or prohibit the use of combination chemotherapy
- •5. Adequate renal, hepatic and cardiac function
- •6. No previous malignancy
- •7. No central nervous system (CNS) involvement with non-Hodgkin's lymphoma
排除标准
- •Patients with lymphoblastic and Burkitt's lymphoma
研究者
相似试验
已完成
3 期
A Phase III, randomized, open-label, comparator-controlled, parallel-group, multicenter study to compare the effects of exenatide and insulin glargine on beta-cell function and cardiovascular risk markers in subjects with type 2 diabetes treated with metformin who have not achieved target HbA1cDiabetes Mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN87762302Eli-Lilly (The Netherlands)75
已完成
3 期
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsEarly-stage Breast CancerNCT00309478Austrian Breast & Colorectal Cancer Study Group1,099
已完成
不适用
A randomized phase IV clinical trial comparing Nadolol and Isosorbide Mononitrate (ISMN) with the combination of Endoscopic Banding Ligation plus Nadolol and ISMN in the prevention of variceal rebleedingVariceal bleedingCirculatory SystemISRCTN26221020Individual Sponsor (Spain)160
已完成
3 期
A randomised phase III clinical trial investigating the effect of Fragmin® added to standard therapy In patients with lung cancerCancerISRCTN80812769Velindre NHS Trust (UK)2,202
已完成
3 期
A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancerSmall cell lung cancerMalignant neoplasm of bronchus or lungCancerISRCTN16174527Sponsor not defined - Record supplied by London Lung Cancer Group724